Jocelyn Solis-Moreira

Feature Writer

B.Sc. Integrative Neuroscience, M.Sc. Psychology

Jocelyn Solis-Moreira graduated with a Bachelor's in Integrative Neuroscience, where she then pursued graduate research looking at the long-term effects of adolescent binge drinking on the brain's neurochemistry in adulthood. She is adept at translating and summarizing complex study findings in all medical fields with a particular interest in neurodegenerative diseases, cancer research, infectious diseases, and public health. As a freelance writer, her work spans from news articles and feature articles to evergreen explainers across many publications. Her overall goal is to make science accessible for all.

Articles from Jocelyn

SARS-CoV-2 Delta variant: A gloomy forecast for the United States

The emergence of the Delta variant (B.1.617.2) in the United States has backtracked many plans to return to a pre-COVID era. A surge in COVID-19 cases due to the Delta variant has caused a rise in COVID-19 deaths and hospitalizations after what was previously a steady decline during the summer.

18 Aug 2021

Study finds high risk groups rejecting the COVID-19 vaccine in England

To increase COVID-19 vaccination rates, public health officials must understand who is refusing the vaccines. New research led by Ben Goldacre from the University of Oxford found that about 2% of people considered high-risk did not want the vaccine when offered. In addition, vaccination refusal in priority groups was most common among English people who are Black, South Asian, or from lower socioeconomic areas.

11 Aug 2021

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

World Health Organization (WHO) guidelines indicate the optimal timing of vaccination among specific groups based on the probability of infection and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), e.g., health care workers providing direct care or acute disease and death (e.g., older people, organ transplant recipients).

11 Aug 2021

How does the mRNA/lipid nanoparticle platform promote protective adaptive immunity against SARS-CoV-2?

Modified mRNA combined with lipid nanoparticles may be beneficial in boosting adaptive immunity against SARS-CoV-2. Research led by Botond Z. Igyártó from Thomas Jefferson University’s Department of Microbiology and Immunology in Pennsylvania recently found that the lipid nanoparticles induce protective adaptive immune responses with antibody titers against lethal doses of the virus.

5 Aug 2021

Could a plant metabolite in liverworts be a potent antiviral against SARS-CoV-2 and other RNA viruses?

A new study from the National Centre for Biotechnology and Medicinal Chemistry Institute suggests Mother Nature delivered — in the form of liverworts. They found that the bryophyte Marchantia polymorpha, also known as umbrella liverworts, could work as a potential antiviral treatment.

5 Aug 2021

CDC scientists model the most efficient physical barrier against SARS-CoV-2 for worker protection

Size doesn’t matter — when it comes to physical barriers in the workplace. A new Centers for Disease Control and Prevention (CDC) study found larger barriers were not statistically better than smaller physical barriers in protecting against severe acute respiratory syndrome 2 (SARS-CoV-2).

2 Aug 2021

Older adults with prior SARS-CoV-2 infection benefit from two doses of Pfizer/BioNTech vaccine

The study by researchers from the Ministry of Health, Madrid, Spain, published in the Center of Disease Control and Prevention’s journal Emerging Infectious Diseases, suggests that long-term care facility residents with prior SARS-CoV-2 infection benefit from full vaccination with the Pfizer/BioNTech (BNT162b2) vaccine.

2 Aug 2021

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

The Centers for Disease Control and Prevention (CDC) issued a letter detailing a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient who did not respond well to monoclonal antibody treatment. The resistance to treatment stemmed from an escape mutation on the spike protein known as Q4923R.

2 Aug 2021

Facebook poll suggests breakthrough infections are linked to long COVID

Ongoing data from a poll via social media found that almost half of the fully vaccinated people who reported breakthrough infections also reported long COVID symptoms.

27 Jul 2021